Hepatic epithelioid hemangioendothelioma, is a rare vascular tumor of undetermined malignant potential. Clinical symptoms and signs are nonspecific, and the diagnosis may be easily missed. We report a case of 23-year-old female who presented with right upper quadrant abdominal pain. Ultrasonography of the abdomen showed multiple discrete nodules in the liver with complex architecture and a hypo echoic centre. Contrast enhanced computed tomography was also performed, which showed peripheral rim enhancement in the arterial phase and "target-sign" in portal and venous phases. These radiological findings suggested metastasis on radiology. However, serum alpha-fetoprotein, CA-125 and carcinoembryonic antigen were within the normal limits. A tru-cut biopsy from the liver nodule showed the presence of tumor cells invading the liver, which was suggestive of epithelioid hemangioendothelioma and later confirmed by CD34 and CD31 immunostains. The patient, presently on thalidomide treatment regimen, is surviving with a stable disease.
INTRODUCTION
Epithelioid hemangioendothelioma is a rare vascular tumor of unpredictable malignant potential known to arise in soft tissue, liver, and lung. [1, 2] Involvement of the liver is rare with incidence of <0.1/1,00,000 population being reported. [3, 4] The clinical presentations and laboratory results including radiology are nonspecific and pose a challenge for diagnosis without any clue. Biopsy with immunohistochemical study along with radiological correlation clinches the diagnosis. We hereby report a rare case of hepatic epithelioid hemangioendothelioma (HEH), with a brief review of literature misdiagnosed as metastatic deposits on radiology and later diagnosed on biopsy, thereby leading to timely diagnosis and avoiding unnecessary work-up to localize a nonexisting primary.
CASE REPORT
A 25-year-old female patient presented with right upper quadrant pain in the abdomen and weight loss of 3 months duration. She was married and had a single child. Her father is a known case of neurofibromatosis. Physical examination revealed hepatomegaly and tenderness in right hypochondrium. Ultrasound of the abdomen [ Figure 1a ] showed multiple discrete hypoechoic nodules in the liver. The internal architecture was mildly complex and heterogeneous with central more hypoechoic nature suggesting central necrosis. Contrast enhanced computed tomography (CT) was also performed, which showed variable degrees of peripheral rim enhancement in the arterial phase [ Figure 1b ]. Portal [ Figure 1c ] and venous [ Figure 1d ] phase images depicted a "target-sign" appearance of tumor nodules. Many of the lesions were peripheral, extending to the capsular margin. Capsular retraction adjacent to the mass lesions was not apparent. Calcifications were not seen. These radiological findings suggested metastatic deposits in the liver. However, serum CA125, carcinoembryonic antigen and alpha-fetoprotein levels were within the normal limits. HBsAg and anti HCV were negative. Liver function test revealed an elevated serum alkaline phosphatase of 235 IU/L. A diagnosis of primary HEH was made and the patient was put on thalidomide treatment regimen who is surviving with a stable disease, on 2 years follow-up.
DISCUSSION
Hepatic epithelioid hemangioendothelioma of liver is a rare neoplasm of vascular origin presenting in the age group between 18 and 86 years. In the study done by Makhlouf et al., [2] the highest tumor incidence was in the age 30-40 years range although in the present case the patient was 25 years old. The tumor shows a slight female predilection (1.6:1-2:1). [2, 5] No confirmed etiologic factor can be blamed, although possible etiologic factors include oral contraceptives, vinylchloride, asbestos, thorotrast, major trauma to the liver, and primary biliary cirrhosis. [3] The symptoms at presentation are nonspecific and may include right upper quadrant pain, weight loss, fever, and rarely jaundice. Many a times (25% of the reported cases) tumor presents as an incidental finding [2, [4] [5] [6] during an abdominal imaging.
The laboratory tests usually show a raised level of serum alkaline phosphatase, [2, 3, 5, 7, 8] as that in our case. However, studies also reported patients with elevated alanine aminotransferase, aspartate aminotransferase, γ-glutamyl transpeptidase and bilirubin although less common than those with elevated alkaline phosphatase. Tumor markers such as serum alpha-fetoprotein, carcinoembryonic antigen, CA-125 and CA-19 levels remain within normal limits, that helps to exclude primary or metastatic carcinomas. [2, 3, 5, 8] Imaging studies of HEH are nonspecific and initial diagnosis is often misdiagnosed as metastatic carcinoma in most of the published reports. Most of the lesions are multiple, peripheral and extend to the liver capsule. Calcification and focal necrosis may be seen. [2, 3, 9, 10] On sonography, some of the reported cases showed bull's eye nodule, as seen in our case. On CT imaging, after intravenous contrast material, most tumors display marginal enhancement during the arterial phase. Of the two types on CT scan, the nodular type is relatively nonspecific, as far as radiological features are concerned. The diffuse pattern is more suggestive with the following features: (1) Large and slow-growing tumor, mainly located in the periphery, without actual bulging of the liver capsule because of its fibrotic structures; (2) peripheral enhancement of contrast medium and the demonstration of many hypervascularized, central lesions with a tendency for the tumor nodules to merge into each other and no traceable sign of the portal or hepatic veins in the CT scan; and (3) pronounced, compensatory hypertrophy of the unaffected liver segments, portal hypertension and splenomegaly, and local calcifications. [3] Definitive diagnosis of the tumor rests with histopathological examination. In general, there are cellular areas consisting of characteristic dendritic and/or epithelioid cells with evidence of vascular differentiation as well as hypocellular stroma, which is sclerotic to myxoid. The cells grow along the sinusoids using it as a scaffold, which eventually obliterates and they infiltrate the adjacent hepatic parenchyma. The stroma is most dense in the center with increasing cellularity at the periphery. As the lesions evolve, the stroma becomes sclerotic. Stromal inflammation was noted in most of the cases, as seen in our case. The vascular nature of the tumor is confirmed by the positive staining with vascular markers such as CD31, CD34 and von Willebrand's factor. The differential diagnoses include fibrolamellar carcinoma, cholangiocarcinoma and metastatic carcinoma. However, these tumors remain strongly positive for epithelial markers and negative for vascular markers. [1] [2] [3] 9, 10] The clinical course of HEH is quite unpredictable, as per literature. Histology is not of much value in predicting the outcome. The treatment modalities include orthotropic liver transplantation, chemotherapy, and radiotherapy. [1] [2] [3] In conclusion Hepatic epithelioid hemangioendothelioma is a vascular tumor with misleading clinical and radiological features. However, biopsy study with a close observation and radiologic correlation allows toward the diagnosis.
